Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood|February 28, 2002
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrixBarbara Carnemolla, Laura Borsi, Enrica Balza, et al.
The Journal of Biological Chemistry|July 28, 2009
Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteinsElisa Ventura, Francesca Sassi, Sara Fossati, et al.
International Journal of Cancer|May 30, 2009
A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain BEnrica Balza, Francesca Sassi, Elisa Ventura, et al.
Annals of the New York Academy of Sciences|October 21, 2010
Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscleMichela Vezzoli, Patrizia Castellani, Lara Campana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic originEnrica Balza, Lorenzo Mortara, Francesca Sassi, et al.
Antioxidants & Redox Signaling|February 8, 2011
High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscleMichela Vezzoli, Patrizia Castellani, Gianfranca Corna, et al.
International Journal of Cancer|September 28, 2002
Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectinLaura Borsi, Enrica Balza, Marco Bestagno, et al.
European Journal of Immunology|November 21, 2007
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalanLorenzo Mortara, Enrica Balza, Francesca Sassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memoryLorenzo Mortara, Patrizia Castellani, Raffaella Meazza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancerMonica Santimaria, Giovanni Moscatelli, Giuseppe L Viale, et al.
Pageof 5